세계의 뇌염 치료 시장 보고서(2025년)

Encephalitis Treatment Global Market Report 2025

US $ 4,490 ￦ 6,426,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,288,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,150,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

뇌염 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.6%로 성장할 전망이며, 278억 5,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 헬스케어 지출 증가, 물리치료 인기 증가, 노인 인구 증가, 뇌염 치료의 인지도 증가에 기인하고 있습니다. 예측 기간 주요 동향에는 선진적인 진단 도구, 뇌염의 진단 및 치료에 대한 인공지능 및 머신러닝, 개별화 의약품 개발, 예방뇌염 백신 수요, 지원 케어 등이 포함됩니다.

뇌염 치료 시장의 성장은 헬스케어 인프라에 대한 투자 증가에 의해 견인될 것으로 예상됩니다. 헬스케어 인프라에는, 첨단 기술을 갖추고, 훈련받은 의료 전문가가 상주하는 병원, 진료소, 의료 연구소 등, 개인 및 지역사회에 대한 의료 제공을 서포트하는 시설, 자원, 서비스가 포함됩니다. 효과적인 헬스케어 인프라는 전문적인 의료시설, 진단도구, 지원케어에 대한 접근성을 제공함으로써 뇌염 치료에 있어 매우 중요한 역할을 하고 있습니다. 예를 들어 2023년 5월 미국의료협회는 미국 병원 수가 2021년 6129개에서 2022년 6,093개로 증가했다고 보고했습니다. 게다가 국가통계국의 보고에 따르면 영국의 헬스케어 지출은 2020-2021년 명목으로 9.4%, 실질적으로 9.7% 급증했습니다. 따라서 헬스케어 인프라 투자의 증가 동향이 뇌염 치료 시장의 성장을 뒷받침하고 있습니다.

뇌염 치료 시장의 성장이 예측되는 배경에는 신경 침습성 질환의 발생률 증가가 있습니다. 신경침습성 질환이란 바이러스 및 세균 등 병원체가 신경계에 침입해 신경조직의 염증이나 손상으로 이어지는 상태를 말합니다. 신경침습성 질환의 유병률 증가는 뇌염 치료에 대한 수요를 창출하고, 확대되는 환자의 요구에 대응하기 위한 새로운 치료법 및 의약품 개발에 대한 제약회사나 연구자의 투자에 박차를 가하고 있습니다. 예를 들면, 2023년 6월, 질병통제예방센터(CDC)는 2022년 7월의 6증례에 대해, 2022년 9월에는 8증례의 신경침습성 라크로스 바이러스 인증을 보고했습니다. 오하이오주는 보고된 총 사례수가 13개로 가장 많아 미국의 다른 지역을 앞질렀습니다. 이는 신경침습성 질환의 사례 수 증가가 뇌염 치료 시장의 성장을 견인하고 있음을 방증하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 뇌염 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 뇌염 치료 시장 : 성장률 분석
• 세계의 뇌염 치료 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 뇌염 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 뇌염 치료 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 뇌염 치료 시장 : 질환 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 원발성 뇌염
• 2차성 뇌염
• 세계의 뇌염 치료 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 항바이러스제
• 스테로이드 주사
• 항생제
• 면역글로불린 요법
• 혈장 교환
• 기타 치료법
• 세계의 뇌염 치료 시장 : 투여 경로별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 오랄
• 비경구
• 기타 투여 경로
• 세계의 뇌염 치료 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 화상 검사
• 혈액 검사
• 생검
• 기타 진단
• 세계의 뇌염 치료 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 전문 클리닉
• 기타 최종 사용자
• 세계의 뇌염 치료 시장 : 원발성 뇌염별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 바이러스성 뇌염
• 세균성 뇌염
• 진균성 뇌염
• 기생충성 뇌염
• 세계의 뇌염 치료 시장 : 2차성 뇌염 분류 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 감염 후 뇌염
• 자가면역성 뇌염
• 전신성 뇌염

제7장 지역별 및 국가별 분석

• 세계의 뇌염 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 뇌염 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 뇌염 치료 시장 : 경쟁 구도
• 뇌염 치료 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson 개요, 제품 및 서비스, 전략 및 재무 분석
  • F. Hoffmann-La Roche 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Bayer AG
• Novartis AG
• Sanofi SA
• Bristol Myers Squibb
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Teva Pharmaceutical Industries
• Regeneron Pharmaceuticals
• Aurobindo Pharma Limited
• Hikma Pharmaceuticals plc
• Vir Biotechnology
• Torrent Pharmaceuticals Ltd.

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 뇌염 치료 시장 : 새로운 기회를 제공하는 국가(2029년)
• 뇌염 치료 시장 : 새로운 기회를 제공하는 부문(2029년)
• 뇌염 치료 시장 : 성장 전략(2029년)
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Encephalitis treatment is the treatment of a medical condition characterized by inflammation of the brain, usually caused by a viral infection, a fungal infection, an autoimmune reaction, or certain medications. Encephalitis treatment is used to manage symptoms, slow down the progression of the disease and prevent complications.

Encephalitis can be categorized into two main types are primary encephalitis and secondary encephalitis. Primary encephalitis involves inflammation originating directly within the brain, rather than being a result of an infection originating elsewhere in the body. Treatment for primary encephalitis includes the use of antiviral medications, supportive care, and symptom management. The various treatment approaches are employed, encompassing antiviral agents, steroid injections, antibiotics, immunoglobulin therapy, plasmapheresis, and other treatments. These treatments can be administered via different routes, including oral, parenteral, and other methods. Diagnosing encephalitis involves employing various types of tests such as imaging tests, blood tests, biopsies, and other diagnostic procedures. These diagnostic tests are conducted by healthcare facilities like hospitals, specialty clinics, and others.

The encephalitis treatment market research report is one of a series of new reports from The Business Research Company that provides encephalitis treatment market statistics, including encephalitis treatment industry global market size, regional shares, competitors with an encephalitis treatment market share, detailed encephalitis treatment market segments, market trends and opportunities and any further data you may need to thrive in the encephalitis treatment industry. This encephalitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The encephalitis treatment market size has grown strongly in recent years. It will grow from $21.09 billion in 2024 to $22.38 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to high incidence of encephalitis, prevalence of viral or bacterial infection, growing government initiatives, rising demand for preventive encephalitis vaccines.

The encephalitis treatment market size is expected to see strong growth in the next few years. It will grow to $27.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to rising healthcare expenditure, increase in the popularity of physical therapy, growing geriatric population, increasing awareness of encephalitis treatment. Major trends in the forecast period include advanced diagnostic tools, ai and ml in encephalitis diagnosis and treatment, development of personalized medicines, demand for preventive encephalitis vaccines, supportive cares.

The growth of the encephalitis treatment market is expected to be driven by increased investments in healthcare infrastructure. Healthcare infrastructure encompasses facilities, resources, and services that support the delivery of medical care to individuals and communities, including hospitals, clinics, and medical laboratories equipped with advanced technology and staffed by trained healthcare professionals. Effective healthcare infrastructure plays a pivotal role in encephalitis treatment by providing access to specialized medical facilities, diagnostic tools, and supportive care. For example, in May 2023, the American Health Care Association reported that the number of hospitals in the US increased from 6,129 in 2021 to 6,093 in 2022. Additionally, healthcare spending in the UK surged by 9.4% in nominal terms and 9.7% in real terms between 2020 and 2021, according to a report by the Office for National Statistics. Therefore, the upward trend in healthcare infrastructure investment is propelling the growth of the encephalitis treatment market.

Anticipated growth in the encephalitis treatment market is attributed to the increasing incidence of neuroinvasive diseases. Neuroinvasive diseases refer to conditions where pathogens like viruses or bacteria enter the nervous system, leading to inflammation or damage to nervous tissues. The growing prevalence of neuroinvasive diseases creates a demand for encephalitis treatments, spurring investments by pharmaceutical companies and researchers in the development of new therapies and medications to address the expanding needs of patients. For example, in June 2023, the Centers for Disease Control and Prevention (CDC) reported 8 cases of neuroinvasive La Crosse virus human disease in September 2022, compared to 6 cases in July 2022. Ohio had the highest total cases reported, with 13 cases, surpassing all other regions in the USA. This underscores the driving force of an increasing number of neuroinvasive disease cases on the encephalitis treatment market's growth.

Leading companies in the encephalitis treatment market are concentrating on strategic investments to speed up the development of innovative therapies, boost their research and development efforts, and expand their clinical trial activities. For example, in September 2023, Arialys Therapeutics, a preclinical-stage company based in the US, raised $58 million in seed funding to advance its lead drug candidate, ART5803, which is aimed at treating anti-NMDA receptor encephalitis (ANRE), a common form of autoimmune encephalitis. The company plans to begin clinical trials with healthy volunteers by the end of 2024, followed by trials in ANRE patients in early 2025. Arialys is dedicated to developing targeted therapies that focus on pathogenic antibodies affecting the central nervous system.

In November 2022, Substipharm, a French pharmaceutical company, acquired the IMOJEV Japanese encephalitis vaccine from Sanofi S.A. for an undisclosed amount. This acquisition enhances Substipharm's position in the encephalitis treatment market and complements its geographic expansion efforts. Sanofi S.A. is a French pharmaceutical company known for manufacturing a wide range of medicines and vaccines, including the encephalitis vaccine.

Major companies operating in the encephalitis treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Vir Biotechnology, Torrent Pharmaceuticals Ltd., Valneva SE, Sangamo Therapeutics, Xenon Pharmaceuticals, Tiziana Life Sciences, Vivet Therapeutics, Tetraphase Pharmaceuticals, QED Therapeutics.

North America was the largest region in the encephalitis treatment market in 2024. The regions covered in encephalitis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the encephalitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The encephalitis treatment market consists of revenues earned by entities by providing plasmapheresis, immunoglobulin therapy, computed tomography (CT scans), magnetic resonance imaging (MRI) and magnetoencephalography (MEG) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The encephalitis treatment market also includes sales of immunosuppressant drugs, antiseizure medicines and immunomodulators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Encephalitis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on encephalitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for encephalitis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The encephalitis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Primary Encephalitis; Secondary Encephalitis
• 2) By Treatment: Antiviral Agents; Steroid Injections; Antibiotics; Immunoglobulin Therapy; Plasmapheresis; Other Treatments
• 3) By Route of Administration: Oral; Parenteral; Other Routes Of Administrations
• 4) By Diagnosis: Imaging Tests; Blood Tests; Biopsy; Other Diagnosis
• 5) By End-User: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Primary Encephalitis: Viral Encephalitis; Bacterial Encephalitis; Fungal Encephalitis; Parasitic Encephalitis
• 2) By Secondary Encephalitis: Post-Infectious Encephalitis; Autoimmune Encephalitis; Encephalitis Due To Systemic
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Encephalitis Treatment Market Characteristics

3. Encephalitis Treatment Market Trends And Strategies

4. Encephalitis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Encephalitis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Encephalitis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Encephalitis Treatment Market Growth Rate Analysis
• 5.4. Global Encephalitis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Encephalitis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Encephalitis Treatment Total Addressable Market (TAM)

6. Encephalitis Treatment Market Segmentation

• 6.1. Global Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Encephalitis
• Secondary Encephalitis
• 6.2. Global Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antiviral Agents
• Steroid Injections
• Antibiotics
• Immunoglobulin Therapy
• Plasmapheresis
• Other Treatments
• 6.3. Global Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administrations
• 6.4. Global Encephalitis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Blood Tests
• Biopsy
• Other Diagnosis
• 6.5. Global Encephalitis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.6. Global Encephalitis Treatment Market, Sub-Segmentation Of Primary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Encephalitis
• Bacterial Encephalitis
• Fungal Encephalitis
• Parasitic Encephalitis
• 6.7. Global Encephalitis Treatment Market, Sub-Segmentation Of Secondary Encephalitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Post-Infectious Encephalitis
• Autoimmune Encephalitis
• Encephalitis Due To Systemic

7. Encephalitis Treatment Market Regional And Country Analysis

• 7.1. Global Encephalitis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Encephalitis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Encephalitis Treatment Market

• 8.1. Asia-Pacific Encephalitis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Encephalitis Treatment Market

• 9.1. China Encephalitis Treatment Market Overview
• 9.2. China Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Encephalitis Treatment Market

• 10.1. India Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Encephalitis Treatment Market

• 11.1. Japan Encephalitis Treatment Market Overview
• 11.2. Japan Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Encephalitis Treatment Market

• 12.1. Australia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Encephalitis Treatment Market

• 13.1. Indonesia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Encephalitis Treatment Market

• 14.1. South Korea Encephalitis Treatment Market Overview
• 14.2. South Korea Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Encephalitis Treatment Market

• 15.1. Western Europe Encephalitis Treatment Market Overview
• 15.2. Western Europe Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Encephalitis Treatment Market

• 16.1. UK Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Encephalitis Treatment Market

• 17.1. Germany Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Encephalitis Treatment Market

• 18.1. France Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Encephalitis Treatment Market

• 19.1. Italy Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Encephalitis Treatment Market

• 20.1. Spain Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Encephalitis Treatment Market

• 21.1. Eastern Europe Encephalitis Treatment Market Overview
• 21.2. Eastern Europe Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Encephalitis Treatment Market

• 22.1. Russia Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Encephalitis Treatment Market

• 23.1. North America Encephalitis Treatment Market Overview
• 23.2. North America Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Encephalitis Treatment Market

• 24.1. USA Encephalitis Treatment Market Overview
• 24.2. USA Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Encephalitis Treatment Market

• 25.1. Canada Encephalitis Treatment Market Overview
• 25.2. Canada Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Encephalitis Treatment Market

• 26.1. South America Encephalitis Treatment Market Overview
• 26.2. South America Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Encephalitis Treatment Market

• 27.1. Brazil Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Encephalitis Treatment Market

• 28.1. Middle East Encephalitis Treatment Market Overview
• 28.2. Middle East Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Encephalitis Treatment Market

• 29.1. Africa Encephalitis Treatment Market Overview
• 29.2. Africa Encephalitis Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Encephalitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Encephalitis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Encephalitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Encephalitis Treatment Market Competitive Landscape
• 30.2. Encephalitis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Encephalitis Treatment Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Sanofi S.A.
• 31.4. Bristol Myers Squibb
• 31.5. Abbott Laboratories
• 31.6. GlaxoSmithKline plc
• 31.7. Takeda Pharmaceutical Company Limited
• 31.8. Eli Lilly and Company
• 31.9. Amgen Inc.
• 31.10. Teva Pharmaceutical Industries
• 31.11. Regeneron Pharmaceuticals
• 31.12. Aurobindo Pharma Limited
• 31.13. Hikma Pharmaceuticals plc
• 31.14. Vir Biotechnology
• 31.15. Torrent Pharmaceuticals Ltd.

32. Global Encephalitis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Encephalitis Treatment Market

34. Recent Developments In The Encephalitis Treatment Market

35. Encephalitis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Encephalitis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Encephalitis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Encephalitis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료